{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:22:13Z","timestamp":1788999733596,"version":"build-2803163510"},"reference-count":143,"publisher":"Elsevier BV","issue":"10","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.autrev.2013.03.013","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T07:32:15Z","timestamp":1364369535000},"page":"1004-1015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":232,"title":["Cardiovascular disease in autoimmune rheumatic diseases"],"prefix":"10.1016","volume":"12","author":[{"given":"Ivana","family":"Hollan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Ahearn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Cohen Tervaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl S.","family":"Goodyear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut A.","family":"Hestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Kahaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Riggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C.","family":"Wasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12016-008-8094-x","article-title":"Atherosclerosis in autoimmune rheumatic diseases\u2014mechanisms and clinical findings","volume":"37","author":"Zinger","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.013_bb0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.autrev.2010.08.002","article-title":"Cardiac involvement in systemic rheumatic diseases: an update","volume":"9","author":"Sarzi-Puttini","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2013.03.013_bb0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.autrev.2009.02.015","article-title":"Cardiovascular risk in rheumatoid arthritis","volume":"8","author":"Nurmohamed","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.013_bb0020","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.autrev.2011.05.022","article-title":"Atherosclerosis in psoriatic arthritis","volume":"10","author":"Ramonda","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.autrev.2013.03.013_bb0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.autrev.2010.06.001","article-title":"How early is the atherosclerotic risk in rheumatoid arthritis?","volume":"9","author":"Bartoloni","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2013.03.013_bb0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.autrev.2011.01.004","article-title":"Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment","volume":"10","author":"Soltesz","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2013.03.013_bb0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.autrev.2011.04.018","article-title":"The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk","volume":"10","author":"Gremese","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2013.03.013_bb0045","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-007-0539-8","article-title":"Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis","volume":"26","author":"Tam","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/acr.20414","article-title":"Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease","volume":"63","author":"Wasko","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/acr.20657","article-title":"Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor alpha therapy","volume":"64","author":"Antohe","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.autrev.2013.03.013_bb0060","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/art.20612","article-title":"Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis","volume":"50","author":"Kremers","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.berh.2012.12.004","article-title":"Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides","volume":"27","author":"Cohen Tervaert","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2249.2009.03885.x","article-title":"Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis","volume":"156","author":"Tervaert","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/rheumatology\/kes345","article-title":"Metabolic syndrome in ANCA-associated vasculitis","volume":"52","author":"Petermann Smits","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.autrev.2013.03.013_bb0080","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/ard.2008.093179","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients","volume":"68","author":"Cervera","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0085","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"21","key":"10.1016\/j.autrev.2013.03.013_bb0095","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.rdc.2005.01.006","article-title":"Inflammation and accelerated atherosclerosis: basic mechanisms","volume":"31","author":"Doria","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.013_bb0105","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.autrev.2012.03.002","article-title":"Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review","volume":"11","author":"Artenjak","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12016-011-8268-9","article-title":"Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome","volume":"44","author":"Gualtierotti","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2013.03.013_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.autrev.2010.09.014","article-title":"Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality","volume":"10","author":"Nussinovitch","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/ar3445","article-title":"Cardiovascular disease in systemic sclerosis\u2014an emerging association?","volume":"13","author":"Ngian","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.autrev.2013.03.013_bb0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/eurheartj\/ehq022","article-title":"Clinical implications of inflammation for cardiovascular primary prevention","volume":"31","author":"Libby","year":"2010","journal-title":"Eur Heart J"},{"issue":"9709","key":"10.1016\/j.autrev.2013.03.013_bb0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.autrev.2013.03.013_bb0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.numecd.2009.07.005","article-title":"Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?","volume":"19","author":"Nordestgaard","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.autrev.2013.03.013_bb0140","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/ard.52.9.677","article-title":"Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis","volume":"52","author":"Winyard","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"10.1016\/j.autrev.2013.03.013_bb0145","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","article-title":"A tale of two diseases: atherosclerosis and rheumatoid arthritis [editorial; comment]","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.ATV.0000251503.35795.4f","article-title":"Biomarkers of atherosclerotic plaque instability and rupture","volume":"27","author":"Koenig","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9313","key":"10.1016\/j.autrev.2013.03.013_bb0155","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.autrev.2013.03.013_bb0160","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2013.03.013_bb0165","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/ar1496","article-title":"Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?","volume":"7","author":"McCarey","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.013_bb0175","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"23","key":"10.1016\/j.autrev.2013.03.013_bb0180","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/eurheartj\/ehp477","article-title":"Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies","volume":"30","author":"Klingenberg","year":"2009","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.013_bb0185","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/1529-0131(200112)44:12<2707::AID-ART456>3.0.CO;2-M","article-title":"Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis","volume":"44","author":"Bacon","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0190","first-page":"33","article-title":"Vascular inflammation in systemic rheumatic diseases","volume":"30","author":"Hollan","year":"2011","journal-title":"Curr Med Lit Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.carpath.2004.02.005","article-title":"B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: preliminary observations","volume":"13","author":"Aubry","year":"2004","journal-title":"Cardiovasc Pathol"},{"issue":"5","key":"10.1016\/j.autrev.2013.03.013_bb0200","first-page":"937","article-title":"Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis","volume":"34","author":"Aubry","year":"2007","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0205","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0021-9150(01)00596-2","article-title":"Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study","volume":"160","author":"Millonig","year":"2002","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0210","first-page":"105","article-title":"Inflammation of the coronary arteries in patients with unstable angina","volume":"13","author":"Wallsh","year":"1986","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.autrev.2013.03.013_bb0215","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0167-5273(96)02811-2","article-title":"Potential role of the adventitia in arteritis and atherosclerosis","volume":"54","author":"Wilcox","year":"1996","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1590\/S0066-782X2002001000003","article-title":"Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries","volume":"79","author":"Higuchi","year":"2002","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5858\/2007-131-481-TROPFI","article-title":"The role of periadventitial fat in atherosclerosis","volume":"131","author":"Vela","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0230","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/ATVBAHA.106.137851","article-title":"Topological determinants and consequences of adventitial responses to arterial wall injury","volume":"27","author":"Michel","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.013_bb0235","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1253\/circj.CJ-08-0473","article-title":"Inflammatory cell infiltrates in vessels with different susceptibility to atherosclerosis in rheumatic and non-rheumatic patients","volume":"72","author":"Hollan","year":"2008","journal-title":"Circ J"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0240","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/art.22690","article-title":"Inflammatory rheumatic disease and smoking are predictors of aortic inflammation: a controlled study of biopsy specimens obtained at coronary artery surgery","volume":"56","author":"Hollan","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0245","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"3 Suppl. 49","key":"10.1016\/j.autrev.2013.03.013_bb0250","first-page":"S131","article-title":"Aortic involvement in ankylosing spondylitis","volume":"26","author":"Palazzi","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2013.03.013_bb0255","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.autrev.2010.02.014","article-title":"Aortic involvement in giant cell arteritis","volume":"9","author":"Martinez-Valle","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.03.013_bb0260","series-title":"Vascular inflammation in rheumatic and non-rheumatic patients: a controlled study of biopsy specimens obtained during coronary artery surgery (Feiring Heart Biopsy Study)","volume":"2-48","author":"Hollan","year":"2009"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0270","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jvs.2005.01.002","article-title":"Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data","volume":"41","author":"Wanhainen","year":"2005","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ije\/dyp320","article-title":"Abdominal aortic aneurysms, or a relatively large diameter of non-aneurysmal aortas, increase total and cardiovascular mortality: the Tromso study","volume":"39","author":"Forsdahl","year":"2010","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0280","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jama.297.4.395","article-title":"Inflammatory abdominal aortic aneurysm","volume":"297","author":"Hellmann","year":"2007","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.013_bb0285","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.autrev.2010.08.001","article-title":"Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases","volume":"9","author":"Atzeni","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0290","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.4049\/jimmunol.0803164","article-title":"Blocking TNF-alpha attenuates aneurysm formation in a murine model","volume":"183","author":"Xiong","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2013.03.013_bb0295","series-title":"Cardiovascular Rheumatology Meeting 2010","article-title":"Heat shock protein 47 expression in the diseased aortic adventitia of patients with and without rheumatoid arthritis","author":"Curran","year":"2010"},{"key":"10.1016\/j.autrev.2013.03.013_bb0305","series-title":"Annual Scientific Meeting of American College of Rheumatology","article-title":"The aortic adventitia of coronary bypass patients with rheumatoid arthritis provides a survival niche, and antigen depot, for B cells","author":"Ahmed","year":"2009"},{"key":"10.1016\/j.autrev.2013.03.013_bb0315","unstructured":"Curran S, Hollan I, Riggio M, Murray C, Goodyear CS, Lapin D. Bacteria in diseased aortic tissue of subjects with and without rheumatoid arthritis. submitted for publication."},{"issue":"5","key":"10.1016\/j.autrev.2013.03.013_bb0320","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jvs.2006.07.021","article-title":"Bacterial diversity in aortic aneurysms determined by 16S ribosomal RNA gene analysis","volume":"44","author":"Marques da","year":"2006","journal-title":"J Vasc Surg"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0325","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/ar2748","article-title":"Broad-range PCR, cloning and sequencing of the full 16S rRNA gene for detection of bacterial DNA in synovial fluid samples of Tunisian patients with reactive and undifferentiated arthritis","volume":"11","author":"Siala","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.autrev.2013.03.013_bb0330","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tripleo.2007.08.015","article-title":"Bacterial diversity in synovial fluids of patients with TMD determined by cloning and sequencing analysis of the 16S ribosomal RNA gene","volume":"105","author":"Sun","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.autrev.2013.03.013_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2013.01.007","article-title":"Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritis.","author":"Hollan","year":"2013","journal-title":"Cardiovasc Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0340","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/acr.20094","article-title":"Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease","volume":"62","author":"Hollan","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0345","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/138161209787354221","article-title":"Anti-inflammatory drugs and statins for arterial stiffness reduction","volume":"15","author":"Maki-Petaja","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0350","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1752-8062.2011.00304.x","article-title":"Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall: a potential role in vascular stiffness and atherosclerosis","volume":"4","author":"Shields","year":"2011","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0355","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0360","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/art.27264","article-title":"Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up-regulation of markers of inflammation in cardiac microvessels and cardiomyocytes","volume":"62","author":"Grundtman","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"15","key":"10.1016\/j.autrev.2013.03.013_bb0365","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/eurheartj\/ehp205","article-title":"Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease","volume":"30","author":"Recio-Mayoral","year":"2009","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0370","first-page":"754","article-title":"Reversing myocardial microvascular disease in a patient with rheumatoid arthritis","volume":"32","author":"Raza","year":"2005","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0375","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3899\/jrheum.110751","article-title":"Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide","volume":"39","author":"Kotyla","year":"2012","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2013.03.013_bb0380","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.amjmed.2003.09.039","article-title":"Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy*1","volume":"116","author":"Wolfe","year":"2004","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.autrev.2013.03.013_bb0385","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3899\/jrheum.100979","article-title":"The influence of rheumatoid arthritis disease characteristics on heart failure","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0390","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1160\/TH06-12-0742","article-title":"Vasa vasorum and atherosclerosis - Quid novi?","volume":"97","author":"Langheinrich","year":"2007","journal-title":"Thromb Haemost"},{"issue":"5 Suppl.","key":"10.1016\/j.autrev.2013.03.013_bb0395","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jacc.2008.09.055","article-title":"The pathologic continuum of diabetic vascular disease","volume":"53","author":"Orasanu","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2013.03.013_bb0400","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0167-5273(00)00196-0","article-title":"Vasa vasoritis, vasculitis and atherosclerosis","volume":"75","author":"Numano","year":"2000","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0405","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1476-5381.2011.01479.x","article-title":"Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target","volume":"165","author":"Aghamohammadzadeh","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.013_bb0410","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.biocel.2011.09.006","article-title":"Epicardial fat: from the biomolecular aspects to the clinical practice","volume":"43","author":"Iacobellis","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0415","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2011.07.012","article-title":"Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice","volume":"219","author":"Ohman","year":"2011","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0420","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3945\/ajcn.2008.27358","article-title":"The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"90","author":"Ding","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0425","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.atherosclerosis.2010.01.007","article-title":"Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study","volume":"210","author":"Lehman","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0430","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.atherosclerosis.2010.02.013","article-title":"Association of pericoronary fat volume with atherosclerotic plaque burden in the underlying coronary artery: a segment analysis","volume":"211","author":"Mahabadi","year":"2010","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.autrev.2013.03.013_bb0435","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/art.27629","article-title":"Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics","volume":"62","author":"Giles","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2013.03.013_bb0440","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjp.0703407","article-title":"Apoptosis in the vasculature: mechanisms and functional importance","volume":"130","author":"Mallat","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0445","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1378\/chest.120.4.1301","article-title":"Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome","volume":"120","author":"Assaly","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2013.03.013_bb0450","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1196\/annals.1422.017","article-title":"Induction of endothelial cell apoptosis by IgG antibodies from SLE patients with nephropathy: a potential role for anti-endothelial cell antibodies","volume":"1108","author":"van","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0455","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","article-title":"Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma","volume":"98","author":"Sgonc","year":"1996","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0460","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"issue":"7143","key":"10.1016\/j.autrev.2013.03.013_bb0465","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature05913","article-title":"Perceptions of epigenetics","volume":"447","author":"Bird","year":"2007","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.autrev.2013.03.013_bb0470","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0475","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cjca.2012.10.023","article-title":"Epigenetics and cardiovascular disease","volume":"29","author":"Webster","year":"2013","journal-title":"Can J Cardiol"},{"issue":"11 Suppl.","key":"10.1016\/j.autrev.2013.03.013_bb0480","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1902\/jop.2005.76.11-S.2085","article-title":"Dental infections and cardiovascular diseases: a review","volume":"76","author":"Mattila","year":"2005","journal-title":"J Periodontol"},{"key":"10.1016\/j.autrev.2013.03.013_bb0485","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ahj.2007.06.037","article-title":"The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis","volume":"154","author":"Bahekar","year":"2007","journal-title":"Am Heart J"},{"issue":"22","key":"10.1016\/j.autrev.2013.03.013_bb0490","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1161\/01.CIR.0000129769.17895.F0","article-title":"Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice","volume":"109","author":"Gibson","year":"2004","journal-title":"Circulation"},{"issue":"Suppl. 10","key":"10.1016\/j.autrev.2013.03.013_bb0495","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-051X.2009.01417.x","article-title":"Periodontitis and risk for atherosclerosis: an update on intervention trials","volume":"36","author":"Tonetti","year":"2009","journal-title":"J Clin Periodontol"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0500","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/BOR.0b013e32835d833d","article-title":"Lessons to be learned from periodontitis","volume":"25","author":"Janssen","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0505","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1902\/jop.2001.72.6.779","article-title":"Relationship between rheumatoid arthritis and periodontitis","volume":"72","author":"Mercado","year":"2001","journal-title":"J Periodontol"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0510","first-page":"656","article-title":"Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs","volume":"24","author":"Moen","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0515","first-page":"2","article-title":"Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis","volume":"7","author":"Ogrendik","year":"2005","journal-title":"MedGenMed"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0520","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1902\/jop.2005.76.2.229","article-title":"Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases","volume":"76","author":"Ramamurthy","year":"2005","journal-title":"J Periodontol"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0525","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1902\/jop.2009.080447","article-title":"Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors","volume":"80","author":"Ortiz","year":"2009","journal-title":"J Periodontol"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0530","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.mehy.2008.12.040","article-title":"Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis","volume":"72","author":"Liao","year":"2009","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.autrev.2013.03.013_bb0535","first-page":"159","article-title":"Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications","volume":"7","author":"Serrano","year":"2011","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0540","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/hrt.2009.186957","article-title":"Depression and cardiac risk: present status and future directions","volume":"96","author":"Frasure-Smith","year":"2010","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0545","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2217\/ijr.11.62","article-title":"Depression in patients with rheumatoid arthritis: description, causes and mechanisms","volume":"6","author":"Margaretten","year":"2011","journal-title":"Int J Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0550","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jad.2011.11.016","article-title":"Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression","volume":"136","author":"Maes","year":"2012","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0555","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.pharmthera.2010.08.007","article-title":"The roles of TNF in brain dysfunction and disease","volume":"128","author":"Clark","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.autrev.2013.03.013_bb0560","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1099-1077(199709\/10)12:5<453::AID-HUP888>3.0.CO;2-4","article-title":"Serotonin Antibodies in Relation to Immune Activation in Major Depression","volume":"12","author":"Sluzewska","year":"1997","journal-title":"Hum Psychopharmacol"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0570","first-page":"135","article-title":"Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE","volume":"27","author":"Galeazzi","year":"2000","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0575","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/PSY.0b013e3182228644","article-title":"Multiwave associations between depressive symptoms and endothelial function in adolescent and young adult females","volume":"73","author":"Tomfohr","year":"2011","journal-title":"Psychosom Med"},{"issue":"8","key":"10.1016\/j.autrev.2013.03.013_bb0580","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.biopsych.2006.03.041","article-title":"Acute depressed mood as a trigger of acute coronary syndromes","volume":"60","author":"Steptoe","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0585","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2011.12.011","article-title":"A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia","volume":"26","author":"Tynan","year":"2012","journal-title":"Brain Behav Immun"},{"issue":"9","key":"10.1016\/j.autrev.2013.03.013_bb0590","doi-asserted-by":"crossref","first-page":"RA205","DOI":"10.12659\/MSM.881924","article-title":"Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis","volume":"17","author":"Wozniak","year":"2011","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0595","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.amjmed.2010.11.015","article-title":"Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients","volume":"124","author":"Scherrer","year":"2011","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0600","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00124509-200312000-00002","article-title":"Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy","volume":"19","author":"Hestad","year":"2003","journal-title":"J ECT"},{"issue":"4","key":"10.1016\/j.autrev.2013.03.013_bb0605","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neubiorev.2013.02.003","article-title":"Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours","volume":"37","author":"Moylan","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0610","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10787-011-0111-7","article-title":"New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors","volume":"20","author":"Maes","year":"2012","journal-title":"Inflammopharmacology"},{"issue":"9504","key":"10.1016\/j.autrev.2013.03.013_bb0615","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","volume":"367","author":"Tyring","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.autrev.2013.03.013_bb0620","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jaad.2009.07.022","article-title":"The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial","volume":"62","author":"Menter","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.autrev.2013.03.013_bb0625","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/kel066","article-title":"Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial","volume":"45","author":"Westhovens","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2013.03.013_bb0630","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/ar2306","article-title":"The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases","volume":"9","author":"Han","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0635","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1751-7117.2009.00028.x","volume":"24","author":"Lichtman","year":"2009","journal-title":"Prog Cardiovasc Nurs"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0640","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.mvr.2010.01.012","article-title":"Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation","volume":"79","author":"Tongers","year":"2010","journal-title":"Microvasc Res"},{"issue":"8","key":"10.1016\/j.autrev.2013.03.013_bb0645","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/rheumatology\/keq388","article-title":"Uric acid and cardiovascular risk in rheumatoid arthritis","volume":"50","author":"Daoussis","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2013.03.013_bb0650","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3899\/jrheum.111076","article-title":"Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis","volume":"39","author":"McCoy","year":"2012","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0655","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/BOR.0b013e32835cfc16","article-title":"Vitamin D deficiency and risk for rheumatic diseases: an update","volume":"25","author":"Gatenby","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2013.03.013_bb0660","doi-asserted-by":"crossref","first-page":"e15235","DOI":"10.1371\/journal.pone.0015235","article-title":"Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis","volume":"5","author":"Smolders","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0665","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/ard.2010.137265","article-title":"Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNFalpha blockade: results from a prospective cohort study","volume":"70","author":"Welsh","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2013.03.013_bb0670","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5664\/jcsm.2254","article-title":"Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors","volume":"8","author":"Walsh","year":"2012","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"10.1016\/j.autrev.2013.03.013_bb0675","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12016-010-8251-x","article-title":"Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy","volume":"44","author":"Bartoloni","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0680","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0685","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/BOR.0b013e3283379b91","article-title":"Cardiovascular disease in rheumatoid arthritis: a step forward","volume":"22","author":"Myasoedova","year":"2010","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2013.03.013_bb0690","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.hjr.0000277983.23934.c9","volume":"14","author":"Graham","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"9426","key":"10.1016\/j.autrev.2013.03.013_bb0695","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.autrev.2013.03.013_bb0700","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.2011.155622","article-title":"Use of statins is associated with an increased risk of rheumatoid arthritis","volume":"71","author":"de Jong","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2013.03.013_bb0705","doi-asserted-by":"crossref","first-page":"e41289","DOI":"10.1371\/journal.pone.0041289","article-title":"Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case\/non-case approach","volume":"7","author":"de Jong","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0710","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2011.06.002","article-title":"Association between statin use and lupus-like syndrome using spontaneous reports","volume":"41","author":"de Jong","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0715","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar3814","article-title":"Statins accelerate the onset of collagen type II-induced arthritis in mice","volume":"14","author":"Vandebriel","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2013.03.013_bb0720","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-013-8359-x","article-title":"Novel mechanisms of action of the biologicals in rheumatic diseases","author":"Chighizola","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2013.03.013_bb0725","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.37723","article-title":"Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis","volume":"65","author":"Wasko","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2013.03.013_bb0730","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/rheumatology\/keq316","article-title":"Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"50","author":"Westlake","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2013.03.013_bb0735","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1749-6632.2009.04645.x","article-title":"Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis","volume":"1173","author":"Kerekes","year":"2009","journal-title":"Ann N Y Acad Sci"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T13:34:09Z","timestamp":1644672849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":143,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1568997213000451"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.03.013","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease in autoimmune rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}